Data Foundry

Drug recalls 2025

Rosuvastatin Tablets 40mg — Class II drug recall D-0339-2025

Ongoing recall by Glenmark Pharmaceuticals Inc., USA, reported 2025-04-16, distributed nationwide. CGMP Deviations

Recall numberD-0339-2025
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmGlenmark Pharmaceuticals Inc., USA, Mahwah, NJ, United States
Recall initiated2025-03-13
Classified2025-04-08
Reported by FDA2025-04-16
DistributedNationwide (US)
Reason classescgmp
NDC68462-0261, 68462-0261-01, 68462-0261-10, 68462-0261-11, 68462-0261-30, 68462-0261-50, 68462-0261-90, 68462-0262, 68462-0262-01, 68462-0262-10, 68462-0262-11, 68462-0262-30, 68462-0262-50, 68462-0262-90, 68462-0263, 68462-0263-01, 68462-0263-10, 68462-0263-11, 68462-0263-30, 68462-0263-50, 68462-0263-90, 68462-0264, 68462-0264-01, 68462-0264-05, 68462-0264-10 and 3 more
Lot numbers17240389, 17240390, 17240426, 17240427, 17240428, 17240778, 17241055, 17241074, 17241075, 17241091, 17241100, APR-26, FEB-26, JUN-26, MAY-26

Product

Rosuvastatin Tablets 40mg, 30-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-264-30

Reason for recall

CGMP Deviations

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0339-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.